Predictors of Refractoriness and Survival following Transarterial Chemoembolization for Hepatocellular Carcinoma: Outcomes from a Southeast Asian Cohort

Rudolf V. Kuhn; Glenn Marc G. Ignacio; Jade D. Jamias; Catherine S.C. Teh

doi:10.1055/s-0042-1756647

Journal of Clinical Interventional Radiology ISVIR (Dec 2023)

Predictors of Refractoriness and Survival following Transarterial Chemoembolization for Hepatocellular Carcinoma: Outcomes from a Southeast Asian Cohort

Rudolf V. Kuhn,
Glenn Marc G. Ignacio,
Jade D. Jamias,
Catherine S.C. Teh

Affiliations

Rudolf V. Kuhn: ORCiD; Department of Medical Imaging and Therapeutic Radiology, National Kidney and Transplant Institute, East Avenue, Quezon City, Philippines
Glenn Marc G. Ignacio: Department of Medical Imaging and Therapeutic Radiology, National Kidney and Transplant Institute, East Avenue, Quezon City, Philippines
Jade D. Jamias: ORCiD; Division of Internal Medicine, National Kidney and Transplant Institute, East Avenue, Quezon City, Philippines
Catherine S.C. Teh: ORCiD; Department of Surgery, National Kidney and Transplant Institute, East Avenue, Quezon City, Philippines

DOI: https://doi.org/10.1055/s-0042-1756647
Journal volume & issue: Vol. 07, no. 03
pp. 141 – 146

Abstract

Read online

Purpose Patients with hepatocellular carcinoma (HCC) become refractory to repeated sessions of transarterial chemoembolization (TACE). The aim of this study was to identify predictors associated with overall survival and refractoriness following repetitive TACE of HCC among patients in Southeast Asia.

Published in Journal of Clinical Interventional Radiology ISVIR

ISSN: 2456-4869 (Online)
Publisher: Thieme Medical Publishers, Inc.
Country of publisher: United States
LCC subjects: Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine
Website: https://doi.org/10.1055/s-00033348

About the journal

Abstract

Keywords